Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors
Phase 1 1 First-In-Human study designed to assess safety , tolerability , right dose for Phase 2...
Read morePhase 1 1 First-In-Human study designed to assess safety , tolerability , right dose for Phase 2...
Read moreLaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) (‘LaFleur Minerals’ or the ‘Company’) is pleased to provide the results...
Read more(TheNewswire) Vancouver, British Columbia June 4 th 2025 TheNewswire – Juggernaut Exploration Ltd. (TSX-V: JUGR) (OTCQB: JUGRF) (FSE: 4JE) (the...
Read moreKey Takeaways: Bitcoin stays strong above $100K, but hasn’t broken out yet — June could be pivotal as institutional flows...
Read moreKey Takeaways: Bitcoin stays strong above $100K, but hasn’t broken out yet — June could be pivotal as institutional flows...
Read more